OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MPPA56

Matahari Putra Prima Tbk PT

Food Retail & DistributionVerified

Matahari Putra Prima Tbk PT has a highly leveraged capital structure, with a debt-to-equity ratio of 7.66, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.75, suggesting that it may struggle to meet short-term obligations without additional financing. Despite this, the company reported positive operating cash flow of 173,010,000,000 IDR and free cash flow of 52,292,000,000 IDR, which provides some buffer for operational needs and debt servicing. Profitability metrics for the company are weak, with a return on equity of -0.1352 and a return on assets of -0.0079, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. These figures are likely below the industry median for the Food Retail & Distribution sector, which typically expects positive returns to sustain operations and growth. The company's revenue is concentrated in the food and drug retailing segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and supply chain disruptions, which could impact its overall performance. The company's growth trajectory appears to be under pressure, with a net loss of 27,285,000,000 IDR reported in the latest financial snapshot. While the company has positive operating cash flow, the net loss suggests that expenses and debt servicing costs are outpacing revenue growth. The outlook for the current fiscal year is not explicitly provided, but the negative net income indicates a challenging operating environment. Risk factors for the company include a high debt load, which could lead to increased financial distress if cash flows decline. The risk assessment indicates a low probability of dilution, but the company's capital structure and liquidity position suggest that it may need to raise additional capital in the future to maintain operations. The company's recent financial performance, including a net loss, may also affect its credit rating and access to financing. Recent events affecting the company include the reported net loss and the high level of debt. The company's financial statements indicate that it has a negative net cash position after subtracting total debt, which could signal financial stress and the need for strategic adjustments to improve liquidity and profitability.

30-day price · MPPA+2.00 (+4.0%)
Low$45.00High$58.00Close$52.00As of12 May, 00:00 UTC
Profile
CompanyMatahari Putra Prima Tbk PT
TickerMPPA.JK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Matahari Putra Prima Tbk PT operates in the food retail and distribution sector, generating revenue primarily through the sale of food and drug products to consumers.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a high confidence level of 0.92.

Matahari Putra Prima Tbk PT has a highly leveraged capital structure, with a debt-to-equity ratio of 7.66, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.75, suggesting that it may struggle to meet short-term obligations without additional financing. Despite this, the company reported positive operating cash flow of 173,010,000,000 IDR and free cash flow of 52,292,000,000 IDR, which provides some buffer for operational needs and debt servicing. Profitability metrics for the company are weak, with a return on equity of -0.1352 and a return on assets of -0.0079, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. These figures are likely below the industry median for the Food Retail & Distribution sector, which typically expects positive returns to sustain operations and growth. The company's revenue is concentrated in the food and drug retailing segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and supply chain disruptions, which could impact its overall performance. The company's growth trajectory appears to be under pressure, with a net loss of 27,285,000,000 IDR reported in the latest financial snapshot. While the company has positive operating cash flow, the net loss suggests that expenses and debt servicing costs are outpacing revenue growth. The outlook for the current fiscal year is not explicitly provided, but the negative net income indicates a challenging operating environment. Risk factors for the company include a high debt load, which could lead to increased financial distress if cash flows decline. The risk assessment indicates a low probability of dilution, but the company's capital structure and liquidity position suggest that it may need to raise additional capital in the future to maintain operations. The company's recent financial performance, including a net loss, may also affect its credit rating and access to financing. Recent events affecting the company include the reported net loss and the high level of debt. The company's financial statements indicate that it has a negative net cash position after subtracting total debt, which could signal financial stress and the need for strategic adjustments to improve liquidity and profitability.
Key takeaways
  • The company has a highly leveraged capital structure with a debt-to-equity ratio of 7.66.
  • Profitability is weak, with a negative return on equity and return on assets.
  • The company's liquidity position is medium, with a current ratio of 0.75.
  • The company reported a net loss of 27,285,000,000 IDR, indicating financial stress.
  • The company's revenue is concentrated in the food and drug retailing segment, with no disclosed geographic diversification.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's margin outlook is negative due to the reported net loss and weak profitability metrics.",
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$1.81T
Gross profit$309.43B
Operating income$6.88B
Net income-$27.29B
R&D
SG&A
D&A
SBC
Operating cash flow$173.01B
CapEx-$19.07B
Free cash flow$52.29B
Total assets$3.45T
Total liabilities$3.25T
Total equity$201.76B
Cash & equivalents
Long-term debt$1.55T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$6.66T-$68.29B-$337.55B$182.22B
FY-3$7.02T-$210.94B-$429.63B$40.53B
FY-2$6.91T-$110.84B-$255.35B$151.30B
FY-1$7.12T$33.92B-$118.11B$224.38B
FY0$7.25T$26.08B-$152.21B$128.43B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$4.65T$584.37B$0.00
FY-3$3.78T$165.98B$4.76B
FY-2$3.64T$259.12B$4.86B
FY-1$3.56T$150.26B
FY0$3.59T-$4.16B
PeriodOCFCapExFCFSBC
FY-4$411.72B-$9.80B$182.22B
FY-3$216.73B-$18.13B$40.53B
FY-2$164.25B-$23.64B$151.30B
FY-1$451.32B-$32.28B$224.38B
FY0$207.85B-$47.64B$128.43B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.81T$6.88B-$27.29B$52.29B
FQ-6$1.65T-$4.17B-$35.08B$49.85B
FQ-5$1.68T$27.67B-$25.68B$56.99B
FQ-4$2.11T$10.20B-$22.30B$61.63B
FQ-3$1.67T-$2.88B-$36.55B$32.93B
FQ-2$1.70T-$2.68B-$32.97B$30.72B
FQ-1$1.78T$21.45B-$60.39B$3.15B
FQ0$2.20T
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$3.45T$201.76B
FQ-6$3.28T$166.69B
FQ-5$3.56T$150.26B
FQ-4$3.77T$127.95B
FQ-3$3.28T$91.41B
FQ-2$3.18T$58.44B
FQ-1$3.59T-$4.16B
FQ0-$2.33B$248.60B
PeriodOCFCapExFCFSBC
FQ-7$173.01B-$19.07B$52.29B
FQ-6$286.94B-$23.48B$49.85B
FQ-5$451.32B-$32.28B$56.99B
FQ-4$158.43B-$8.79B$61.63B
FQ-3$194.59B-$15.45B$32.93B
FQ-2$246.27B-$31.29B$30.72B
FQ-1$207.85B-$47.64B$3.15B
FQ0$94.58B-$15.83B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$201.76B
Net cash-$1.55T
Current ratio0.8
Debt/Equity7.7
ROA-0.8%
ROE-13.5%
Cash conversion-6.3%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricMPPAActivity
Op margin0.4%3.1% medp25 1.2% · p75 6.8%bottom quartile
Net margin-1.5%2.0% medp25 0.7% · p75 4.1%bottom quartile
Gross margin17.1%26.1% medp25 17.2% · p75 32.0%bottom quartile
CapEx / revenue-1.1%-2.5% medp25 -4.6% · p75 -1.4%top quartile
Debt / equity766.0%56.0% medp25 16.8% · p75 121.1%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:14 UTC#25c122f7
Market quoteclose IDR 52.00 · shares 12.97B diluted
no public URL
2026-05-12 00:14 UTC#a087c689
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 15:33 UTCJob: cbbe3ebc